Cancer patient access to unapproved treatments :
hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, February 29, 1996.
|Corporate Author:||United States.|
Washington : U.S. G.P.O. : 1996.
United States. /
Food and Drug Administration.
Clinical trials > Clinical trials / United States.
Antineoplastic agents > Antineoplastic agents / United States.
Therapeutics, Experimental > Therapeutics, Experimental / United States.
Antineoplaston treatment > Antineoplaston treatment / United States.
Cancer > Cancer / Patients > Cancer / Patients / United States.
Cancer > Cancer / Treatment > Cancer / Treatment / United States.
iii, 71 p. ;
|Locate a Print Version:||
Find in a library
|Item Link||Original Source|
|Full view||University of California|
|Full view4.C 73/8:104-60||Pennsylvania State University|